Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
Lowe's 将上涨约 19%？以下是周四的其他 10 项目标价格变动
- Goldman Sachs raised Lowe's Companies, Inc. (NYSE:LOW) price target from $241 to $246. . Goldman Sachs analyst Kate McShane maintained a Buy rating on the stock. Lowe's shares fell 0.1% to $206.70 in pre-market trading.
- Stephens & Co. boosted NCR Corporation (NYSE:NCR) price target from $28 to $32. Stephens & Co. analyst Charles Nabhan maintained an Overweight rating on the stock. NCR rose 0.3% to close at $22.87 on Wednesday.
- Credit Suisse raised the price target on Campbell Soup Company (NYSE:CPB) from $52 to $54. Credit Suisse analyst Robert Moskow maintained a Neutral rating on the stock. Campbell Soup shares fell 0.1% to $56.11 in pre-market trading.
- Raymond James cut GDS Holdings Limited (NASDAQ:GDS) price target from $55 to $35. Raymond James analyst Frank Louthan maintained an Outperform rating on the stock. GDS Holdings shares rose 7.6% to $18.89 in pre-market trading.
- JP Morgan cut Martin Marietta Materials, Inc. (NYSE:MLM) price target from $410 to $395. JP Morgan analyst Adrian Heurta maintained an Overweight rating on the stock. Martin Marietta Materials shares gained 0.7% to close at $352.50 on Wednesday.
- BTIG boosted Prometheus Biosciences, Inc. (NASDAQ:RXDX) price target from $74 to $181. BTIG analyst Julian Harrison maintained a Buy rating on the stock. Prometheus Biosciences shares jumped 9.4% to $104.84 in pre-market trading.
- Oppenheimer cut Mirati Therapeutics, Inc. (NASDAQ:MRTX) price target from $85 to $60. Oppenheimer analyst Jay Olson maintained the stock with a Perform. Mirati Therapeutics Limited shares fell 0.2% to $49.47 in pre-market trading.
- HC Wainwright & Co. cut Gossamer Bio, Inc. (NASDAQ:GOSS) price target from $25 to $5. Gold HC Wainwright & Co. analyst Patrick Trucchio maintained a Buy rating on the stock. Gossamer Bio shares fell 1.8% to $2.12 in pre-market trading.
- Baird cut Salesforce, Inc. (NYSE:CRM) price target from $200 to $150. Baird analyst Rob Oliver downgraded the stock from Outperform to Neutral. Salesforce shares fell 0.9% to $129.37 in pre-market trading.
- Jefferies cut Lumos Pharma, Inc. (NASDAQ:LUMO) price target from $17 to $7. Jefferies analyst Eun Yang downgraded the stock from Buy to Hold. Lumos Pharma shares fell 11.2% to close at $4.46 on Wednesday.
- UBS boosted The Hershey Company (NYSE:HSY) price target from $244 to $269. UBS analyst Cody Ross upgraded the stock from Neutral to Buy. Hershey shares rose 1.2% to $239.61 in pre-market trading.
- 高盛募集资金劳氏公司。(纽约证券交易所：低价)目标从241美元降至246美元。。高盛分析师凯特·麦克肖恩维持对该股的买入评级。在盘前交易中，劳氏股价下跌0.1%，至206.70美元。
- 斯蒂芬斯公司股价上涨NCR公司(纽约证券交易所代码：NCR)目标价从28美元降至32美元。Stephens&Co.分析师纳布汉(Charles Nabhan)对该股维持增持评级。NCR周三上涨0.3%，收报22.87美元。
- 瑞士信贷上调了目标价金宝汤公司(纽约证券交易所代码：CPB)从52美元升至54美元。瑞士信贷分析师罗伯特·莫斯科夫对该股维持中性评级。在盘前交易中，Campbell Soup股价下跌0.1%，至56.11美元。
- 雷蒙德·詹姆斯·卡特尔万国数据(纳斯达克代码：GDS)目标价从55美元降至35美元。Raymond James分析师Frank Louthan对该股维持表现优于大盘的评级。在盘前交易中，万国数据的股价上涨了7.6%，至每股18.89美元。
- 摩根大通降息马丁·玛丽埃塔材料公司(纽约证券交易所代码：MLM)目标价从410美元降至395美元。摩根大通分析师禤浩焯·赫尔塔维持对该股的增持评级。马丁·玛丽埃塔材料公司股价周三上涨0.7%，收于352.50美元。
- BTIG得到提振普罗米修斯生物科学公司(纳斯达克：RXDX)目标价从74美元降至181美元。BTIG分析师朱利安·哈里森对该股维持买入评级。在盘前交易中，普罗米修斯生物科学公司的股价跃升9.4%，至104.84美元。
- 奥本海默切割米拉蒂治疗公司(纳斯达克：MRTX)目标价从85美元降至60美元。奥本海默分析师杰伊·奥尔森维持了该股的表现。在盘前交易中，Mirati Treateutics Limited的股价下跌0.2%，至49.47美元。
- HC Wainwright&Co.Cut薄荷生物股份有限公司(纳斯达克代码：戈斯)目标价从25美元降至5美元。Gold HC Wainwright&Co.分析师帕特里克·楚奇奥维持对该股的买入评级。在盘前交易中，Gossamer Bio股价下跌1.8%，至2.12美元。
- Baird CutSalesforce，Inc.(纽约证券交易所代码：CRM)目标价从200美元降至150美元。Baird分析师罗布·奥利弗将该股评级从强于大盘下调至中性。Salesforce股价在盘前交易中下跌0.9%，至129.37美元。
- 杰富瑞削减卢莫斯制药公司(纳斯达克股票代码：Lumo)目标价从17美元下调至7美元。杰富瑞分析师Eun Yang将该股评级从买入下调至持有。Lumos Pharma股价周三下跌11.2%，收于4.46美元。
- 瑞银股价上涨好时公司(纽约证券交易所代码：HSY)目标价从244美元降至269美元。瑞银分析师科迪·罗斯将该股评级从中性上调至买入。好时股价在盘前交易中上涨1.2%，至239.61美元。
Check out this: Why These Lululemon Analysts Have Boosted Their Price Targets Ahead Of Earnings
看看这个：为什么这些lululemon分析师在盈利之前上调了目标价